PetMed CFO says allegations of marketing to opioid addicts are 'bogus'

SAN FRANCISCO (Reuters) - A short seller's allegations that PetMed Express markets pet medicine to human opioid addicts are "bogus," PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.